Literature DB >> 23870413

Adequacy of opioid analgesic consumption at country, global, and regional levels in 2010, its relationship with development level, and changes compared with 2006.

Béatrice Duthey1, Willem Scholten2.   

Abstract

CONTEXT: In most countries, patients do not have adequate access to opioid analgesics because of barriers resulting from the abuse potential of these medicines.
OBJECTIVES: To provide an analysis for the adequacy of the consumption of opioid analgesics for countries and World Health Organization regions in 2010 as compared with 2006.
METHODS: We calculated the Adequacy of Consumption Measure using data for 2010 based on a method established by Seya et al. This method calculates the morbidity-corrected needs per capita for relevant strong opioid analgesics and the actual use for the top 20 Human Development Index countries. It determines the adequacy of the consumption for each country, World Health Organization region, and the world by comparing the actual consumption with the calculated need. Furthermore, the method allows us to calculate the number of people living in countries at various levels of adequacy. We compared our outcomes with data from Seya et al. for 2006.
RESULTS: Most people have no access to opioids for pain relief in case of need; 66% of the world population has virtually no consumption, 10% very low, 3% low, 4% moderate, and only 7.5% adequate. For 8.9%, no data are available. Between 2006 and 2010, 67 countries increased the adequacy of opioid consumption per capita. These changes are independent of countries' level of development.
CONCLUSION: The consumption of opioid analgesics remains inadequate in most of the world and, as a result, patients with moderate and severe pain do not receive the treatment they need. Governments, health organizations, and nongovernmental organizations must collaborate to address this situation, targeting their efforts at educational, cultural, health policy and regulatory levels.
Copyright © 2014 World Health Organization. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Opioid analgesics; access; controlled medicines; health policy; morphine; pain treatment; palliative care

Mesh:

Substances:

Year:  2013        PMID: 23870413     DOI: 10.1016/j.jpainsymman.2013.03.015

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  35 in total

Review 1.  The prescription opioid crisis: role of the anaesthesiologist in reducing opioid use and misuse.

Authors:  Ellen M Soffin; Bradley H Lee; Kanupriya K Kumar; Christopher L Wu
Journal:  Br J Anaesth       Date:  2018-12-28       Impact factor: 9.166

2.  Quantifying the Adequacy of Opioid Analgesic Consumption Globally: An Updated Method and Early Findings.

Authors:  Willem K Scholten; Ann-Eva Christensen; Anne Estrup Olesen; Asbjørn Mohr Drewes
Journal:  Am J Public Health       Date:  2018-11-29       Impact factor: 9.308

3.  Do national drug control laws ensure the availability of opioids for medical and scientific purposes?

Authors:  S Asra Husain; Marty Skemp Brown; Martha A Maurer
Journal:  Bull World Health Organ       Date:  2013-11-26       Impact factor: 9.408

4.  A review of patients with advanced cervical cancer presenting to palliative care services at Queen Elizabeth Central Hospital in Blantyre, Malawi.

Authors:  M J Bates; A Mijoya
Journal:  Malawi Med J       Date:  2015-09       Impact factor: 0.875

Review 5.  Global Supply and Demand of Opioids for Pain Management.

Authors:  Sreekumar Kunnumpurath; Natasha Julien; Gopal Kodumudi; Anamika Kunnumpurath; Vijay Kodumudi; Nalini Vadivelu
Journal:  Curr Pain Headache Rep       Date:  2018-04-04

Review 6.  Cancer control in the Pacific: big challenges facing small island states.

Authors:  Diana Sarfati; Rachel Dyer; Filipina Amosa-Lei Sam; Michael Barton; Freddie Bray; Eka Buadromo; Alec Ekeroma; Sunia Foliaki; James Fong; Josephine Herman; Linda Huggins; Kiki Maoate; Ineke Meredith; Glen Mola; Neal Palafox; Viliami Puloka; Hai-Rim Shin; Jane Skeen; Wendy Snowdon; Malama Tafuna'i; Andrea Teng; David Watters; Paula Vivili
Journal:  Lancet Oncol       Date:  2019-08-05       Impact factor: 41.316

7.  Consumption trend and prescription pattern of opioid analgesics in China from 2006 to 2015.

Authors:  Wentong Fang; Tingting Liu; Zhongsheng Gu; Qian Li; Can Luo
Journal:  Eur J Hosp Pharm       Date:  2018-01-27

8.  National consumption of opioid and nonopioid analgesics in Croatia: 2007-2013.

Authors:  Darko Krnic; Andrea Anic-Matic; Svjetlana Dosenovic; Pero Draganic; Sasa Zezelic; Livia Puljak
Journal:  Ther Clin Risk Manag       Date:  2015-08-28       Impact factor: 2.423

9.  Ready conversion of patients with well-controlled, moderate to severe, chronic malignant tumor-related pain on other opioids to tapentadol extended release.

Authors:  Keiichiro Imanaka; Yushin Tominaga; Mila Etropolski; Hiroki Ohashi; Keiichiro Hirose; Taka Matsumura
Journal:  Clin Drug Investig       Date:  2014-07       Impact factor: 2.859

Review 10.  A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain.

Authors:  Joseph V Pergolizzi; Gianpietro Zampogna; Robert Taylor; Edmundo Gonima; Jose Posada; Robert B Raffa
Journal:  Front Pharmacol       Date:  2016-03-01       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.